2,156
Views
13
CrossRef citations to date
0
Altmetric
Pharmacotherapy

Treatment patterns among non-active users of maintenance asthma medication in the United Kingdom: a retrospective cohort study in the Clinical Practice Research Datalink

, MBBS, MPH, PhD, DFPH, FRSPHORCID Icon, , MBBS, MSc, MBAORCID Icon, , MScORCID Icon, , MHSORCID Icon, , OBE, MSc, DipN, DipHVORCID Icon, , BPharm, PhDORCID Icon & , MB, BChir, MA, DRCOG, FRCGPORCID Icon show all
Pages 793-804 | Received 11 Sep 2019, Accepted 09 Feb 2020, Published online: 23 Feb 2020

References

  • Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma. The Lancet. 2018;391(10122):783–800. doi:10.1016/S0140-6736(17)33311-1.
  • Global I. for Asthma. Global Strategy for Asthma Management and Prevention; 2018 [Accessed 28 May. 2019; https://www.ginaasthma.org.
  • Kant S. Socio-economic dynamics of asthma. Indian J Med Res. 2013;138(4):446–448.
  • British Thoracic Society, Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma – A National Clinical Guideline. 2016. Available from: https://www.brit-thoracic.org.uk/standards-of-care/guidelines/btssign-british-guideline-on-the-management-of-asthma [last accessed 28 May 2019].
  • National Heart, Lung, and Blood Institute. Guidelines for the Diagnosis and Management of Asthma (EPR-3. ). Bethesda: National Institutes for Health; 2007. Available from: https://www.nhlbi.nih.gov/health-topics/guidelines-for-diagnosis-management-of-asthma [accessed 28 May 2019].
  • National Asthma Council Australia. Australia’s National Guidelines for Asthma Management. 2018. Available from: https://www.asthmahandbook.org.au/management/adults [accessed 28 May 2019].
  • Busse WW, Pedersen S, Pauwels RA, Tan WC, Chen Y-Z, Lamm CJ, O'Byrne PM, on behalf of the START Investigators Group The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: Effectiveness of early intervention with budesonide in mild persistent asthma. J Allergy Clin Immunol. 2008;121(5):1167–1174.
  • Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, Pedersen SE. GOAL Investigators Group. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med. 2004;170(8):836–844. doi:10.1164/rccm.200401-033OC.
  • Small M, Anderson P, Vickers A, Kay S, Fermer S. Importance of inhaler-device satisfaction in asthma treatment: real-world observations of physician-observed compliance and clinical/patient-reported outcomes. Adv Therapy. 2011;28(3):202–212. doi:10.1007/s12325-010-0108-4.
  • Price DB, Colice G, Israel E, Roche N, Postma DS, Guilbert TW, van Aalderen WMC, Grigg J, Hillyer EV, Thomas V, et al. Add-on LABA in a separate inhaler as asthma step-up therapy versus increased dose of ICS or ICS/LABA combination inhaler. ERJ Open Res. 2016;2(2):00106-2015–2015. doi:10.1183/23120541.00106-2015.
  • Rank MA, Branda ME, McWilliams DB, Johnson SK, Samant SA, Podjasek JC, Park MA, Volcheck GW. Outcomes of stepping down asthma medications in a guideline-based pediatric asthma management program. Ann Allergy Asthma Immunol. 2013;110(5):354–358.e2. doi:10.1016/j.anai.2013.02.012.
  • Rank MA, Liesinger JT, Branda ME, Gionfriddo MR, Schatz M, Zeiger RS, Shah ND. Comparative safety and costs of stepping down asthma medications in patients with controlled asthma. J Allergy Clin Immunol. 2016;137(5):1373–1379. doi:10.1016/j.jaci.2015.08.035.
  • Turner SW, Richardson K, Burden A, Thomas M, Murray C, Price D. Initial step-up treatment changes in asthmatic children already prescribed inhaled corticosteroids: a historical cohort study. NPJ Prim Care Respir Med. 2015;25:15041doi:10.1038/npjpcrm.2015.41.
  • Turner S, Richardson K, Murray C, Thomas M, Hillyer EV, Burden A, Price DB. Long-acting beta-agonist in combination or separate inhaler as step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. J Allergy Clin Immunol Pract. 2017;5(1):99–106. doi:10.1016/j.jaip.2016.06.009.
  • Clinical Practice Research Datalink. Available from www.cprd.com/home.
  • Herrett E, Gallagher AM, Bhaskaran K, Forbes H, Mathur R, van Staa T, Smeeth L. Data resource profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol. 2015;44(3):827–836. doi:10.1093/ije/dyv098.
  • Suruki RY, Daugherty JB, Boudiaf N, Albers FC. The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA. BMC Pulm Med. 2017;17(1):74. doi:10.1186/s12890-017-0409-3.
  • Pearson MG, Bucknall CE. Measuring clinical outcome in asthma: a patient focused approach. London: Royal College of Physicians; 1999. doi:10.1046/j.1365-2753.2002.00346.x.
  • Pinnock H, Burton C, Campbell S, Gruffydd-Jones K, Hannon K, Hoskins G, Lester H, Price D. Clinical implications of the Royal College of Physicians three questions in routine asthma care: a real-life validation study. Prim Care Respir J. 2012; 21(3):288–294. doi:10.4104/pcrj.2012.00052.
  • Quality and Outcomes Framework (QOF) business rules v 38 2017-2018 October code release; October 2018. Available from: https://digital.nhs.uk/data-and-information/data-collections-and-data-sets/data-collections/quality-and-outcomes-framework-qof/quality-and-outcome-framework-qof-business-rules/quality-and-outcomes-framework-qof-business-rules-v-38-2017-2018-october-code-release [last accessed 3 July 2019].
  • Joint Formulary Committee. British National Formulary (online) London: BMJ Group and Pharmaceutical Press. Available from: https://www.medicinescomplete.com [last accessed 15 February 2019].
  • Gayle A, Tebboth A, Pang M, Guelfucci F, Argoubi R, Sherman S, Mak V. 2014. Real-life prescribing of asthmatic treatments in UK general practice over time using 2014. BTS/SIGN steps. NPJ Prim Care Respir Med. 2019;29:25. doi:10.1038/s41533-019-0137-7.
  • Reddel HK, Sawyer SM, Everett PW, Flood PV, Peters MJ. Asthma control in Australia: a cross-sectional web-based survey in a nationally representative population. Med J Aust. 2015;202(9):492–498. doi:10.5694/mja14.01564.
  • Price D, Fletcher M, van der Molen T. Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ Prim Care Respir Med. 2014;24:14009. doi:10.1038/npjpcrm.2014.9.
  • Janson C, Accordini S, Cazzoletti L, Cerveri I, Chanoine S, Corsico A, Ferreira DS, Garcia-Aymerich J, Gislason D, Nielsen R, et al. Pharmacological treatment of asthma in a cohort of adults during a 20-year period: results from the European Community Respiratory Health Survey I, II and III. ERJ Open Res. 2019;5(1):00073-2018–2018. doi:10.1183/23120541.00073-2018.
  • Nissen F, Douglas IJ, Müllerová H, Pearce N, Bloom CI, Smeeth L, Quint JK. Clinical profile of predefined asthma phenotypes in a large cohort of UK primary care patients (Clinical Practice Research Datalink). JAA. 2019;12:7–19. doi:10.2147/JAA.S182013.
  • Miller MK, Lee JH, Miller DP, Wenzel SE. Recent asthma exacerbations: a key predictor of future exacerbations. Respir Med. 2007;101(3):481–489. doi:10.1016/j.rmed.2006.07.005.
  • Price D, Wilson AM, Chisholm A, Rigazio A, Burden A, Thomas M, King C. Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice. J Asthma Allergy. 2016;9:1–12. doi:10.2147/JAA.S97973.
  • Blakey JD, Price DB, Pizzichini E, Popov TA, Dimitrov BD, Postma DS, Josephs LK, Kaplan A, Papi A, Kerkhof M, et al. Identifying Risk of Future Asthma Attacks Using UK Medical Record Data: A Respiratory Effectiveness Group Initiative. J Allergy Clin Immunol Pract. 2017;5(4):1015–1024. doi:10.1016/j.jaip.2016.11.007.
  • Turner SW, Murray C, Thomas M, Burden A, Price DB. Applying UK real-world primary care data to predict asthma attacks in 3776 well-characterised children: a retrospective cohort study. NPJ Prim Care Respir Med. 2018;28(1):28doi:10.1038/s41533-018-0095-5.
  • Ismaila A, Corriveau D, Vaillancourt J, Parsons D, Stanford R, Su Z, Sampalis JS. Impact of adherence to treatment with fluticasone propionate/salmeterol in asthma patients. Curr Med Res Opin. 2014;30(7):1417–1425. doi:10.1185/03007995.2014.908827.
  • Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention; 2019. Available from: https://www.ginaasthma.org [last accessed 3 July 2019].
  • Royal College of Physicians National review of asthma deaths Why asthma still kills report and key recommendations. http://www.rcplondon.ac.uk/projects/national-review-asthma-deaths [last accessed 20 May 2019].
  • Levy ML, Garnett F, Kuku A, Pertsovskaya I, McKnight E, Haughney J. A review of asthma care in 50 general practices in Bedfordshire, United Kingdom. NPJ Prim Care Respir Med. 2018;28:29. doi:10.1183/13993003.congress-2018.PA4205.
  • Asthma UK. 2009. ‘The reality of asthma care in the UK’. Annual Asthma Survey 2018 Report. https://www.asthma.org.uk/support-us/campaigns/publications/survey/ [last accessed 20 May 2019].